No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Goldman Sachs Maintains Amicus Therapeutics(FOLD.US) With Hold Rating, Maintains Target Price $14
Wells Fargo Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $18
Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook
Amicus Stock Surges on Positive 2024 Revenue Outlook
TD Cowen Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $20
A Quick Look at Today's Ratings for Amicus Therapeutics(FOLD.US), With a Forecast Between $12 to $20